Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.5100
+0.0100 (2.00%)
Nov 11, 2026, 4:10 PM AEDT
Nyrada Market Cap
Nyrada has a market cap or net worth of 126.27 million as of November 10, 2026. It is the 25,904th most valuable company in the world and the 552nd biggest in Australia. Its market cap has decreased by 32.41% in one year.
Market Cap
126.27M
Enterprise Value
117.89M
Revenue
2.01M
Global Rank
Country Rank
#552 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 126.27M, an increase of 391.23%. That is a compound annual growth rate of 26.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 126.27M | -53.65% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 215.88M |
| BLS Pharmaceuticals | 202.67M |
| Actinogen Medical | 184.70M |
| Orthocell | 160.71M |
| Paradigm Biopharmaceuticals | 153.48M |
| Dimerix | 132.09M |
| Recce Pharmaceuticals | 105.49M |
| Island Pharmaceuticals | 96.23M |